Genetic analysis of the APC gene regions involved in attenuated APC phenotype in Israeli patients with early onset and familial colorectal cancer

por Figer, A, Irmin, L, Geva, R, Flex, D, Sulkes, A, Friedman, E
Publicado 2001

The rate of the 6174delT founder Jewish mutation in BRCA2 in patients with non-colonic gastrointestinal tract tumours in Israel

por Figer, A, Irmin, L, Geva, R, Flex, D, Sulkes, J, Sulkes, A, Friedman, E
Publicado 2001

Association of the I1307K APC mutation with hereditary and sporadic breast/ovarian cancer: more questions than answers

por Gershoni-Baruch, R, Patael, Y, Dagan, Figer, A, Kasinetz, L, Kadouri, E, Sade, R Bruchim Bar, Friedman, E
Publicado 2000

The frequency of the predominant Jewish mutations in BRCA1 and BRCA2 in unselected Ashkenazi colorectal cancer patients

por Chen-Shtoyerman, R, Figer, A, Fidder, H H, Rath, P, Yeremin, L, Meir, S Bar, Friedman, E, Theodor, L
Publicado 2001

XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results

por Cassidy, J, Clarke, S, Díaz-Rubio, E, Scheithauer, W, Figer, A, Wong, R, Koski, S, Rittweger, K, Gilberg, F, Saltz, L
Publicado 2011

Phenotypic characteristics of colo-rectal cancer in I1307K APC germline mutation carriers compared with sporadic cases

por Figer, A, Shtoyerman-Chen, R, Tamir, A, Geva, R, Irmin, L, Flex, D, Theodor, L, Sulkes, A, Sadetzki, S, Bar-Meir, S, Friedman, E
Publicado 2001

Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial

por Cassidy, J, Douillard, J-Y, Twelves, C, McKendrick, J J, Scheithauer, W, Bustová, I, Johnston, P G, Lesniewski-Kmak, K, Jelic, S, Fountzilas, G, Coxon, F, Díaz-Rubio, E, Maughan, T S, Malzyner, A, Bertetto, O, Beham, A, Figer, A, Dufour, P, Patel, K K, Cowell, W, Garrison, L P
Publicado 2006